* to better understand and improve appropriate CCA prevention and treatment. To identify the candidate genes underlying Ov-induced CCA, we have previously investigated candidate genes that may underly Ov and NDMA-induced CCA in a hamster animal model and found that 1 downregulated and 23 upregulated transcripts are involved in CCA development (Loilome et al., 2006) . Among the upregulated genes, the signal transduction protein kinase A regulatory subunit Iα (Prkar1a) has been observed to be involved in CCA development and progression (Loilome et al., 2006) . Moreover, Prkar1a inhibition lead to apoptosis in CCA cells together with a decrease in several protein kinase pathways, including PI3K/AKT, Wnt/β-catenin, JAK/STAT and MAPK signaling (Loilome et al., 2011) . Recently, we have reported multiple kinases that are activated in both CCA cell lines and human CCA tissues, including the PI3K/ AKT, Wnt/β-catenin, JAK/STAT and MAPK signaling pathways . Furthermore, we
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have demonstrated that the constitutive activation of PI3K/AKT pathway in human CCA tissues is due to the loss of PTEN expression as well as PTEN inactivation. Moreover, inhibition of PI3K/AKT pathway showed anti-cancer activity against CCA cells (Yothaisong et al., 2013) . Apart from PI3K/AKT, we have also recently demonstrated the abundant expression of the Wnt protein family and β-catenin in human CCA tissues. Interestingly, inflammatory condition can cause Wnt/β-catenin activation in CCA cells (Loilome et al., 2014) . The present study examined whether the alteration of PI3K/AKT/PTEN and Wnt/β-catenin signaling pathway occured during Ov-induced CCA carcinogenesis in a hamster model. The results can provide insights into the molecular mechanism(s) which drive CCA development in order to develop therapeutic strategies to prevent CCA carcinogenesis.
Materials and Methods

Animals and tumor induction
The animal experiments were conducted according to the guidelines of the National Committee of Animal Ethics and the protocol was approved by the Animal Ethics Committee of the Faculty of Medicine, Khon Kaen University, Thailand (#AE002/2002 ). An induction of CCA in hamsters was done by combination treatment between Ov metacercariae infection and NDMA according to a previous study (Loilome et al., 2006) . Male Syrian golden hamsters aged 6-8 weeks were divided into 2 groups: Group 1 was untreated and served as the control group; Group 2 was fed 50 Ov metacercariae by intragastric intubation combined with oral administration of 12.5 ppm NDMA (Sigma,St. Louis, MO, USA) for 2 months. Animals were fed a stock diet and water ad libitum, housed under conventional conditions, and were sacrificed on days 14, 30, 90 and 180 after treatment. Liver tissue was collected and fixed in 10% (v/v) neutral buffered formalin and embedded in paraffin according to standard techniques. Samples were used for histological and immunohistochemical examinations.
Immunohistochemical analysis
An alteration of several key protein components of the PI3K/AKT/PTEN and Wnt/β-catenin signaling pathways during CCA carcinogenesis was investigated by immunohistochemistry (IHC) staining. According to the IHC standard method, the paraffin embedded tissues were sectioned and mounted on poly-lysine-coated glass slides and air-dried overnight at room temperature, followed by deparaffinization with xylene for 5 min, two times. Slides were then rehydrated by decreasing concentrations of ethanol in twice for 5 min as follows: 100% ethanol, 90% ethanol, 80% ethanol and 70% ethanol. Rehydrated sections were kept in phosphate buffered saline (PBS) with subsequent by antigen retrieval in 100 mM sodium citrate buffer (pH 6.0) for 10 min in microwave oven. Sections were immersed in 0.3% hydrogen peroxide in PBS (V/V) for 30 min in order to quench their endogenous peroxidase activity. After blocking with 10% skim milk (w/v) in PBS for 45 min, the sections were incubated with the diluted primary antibody in PBS at 4 o C overnight, as listed in DOI:http://dx.doi.org/10.7314/APJCP.2014.15.23 
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in PBS, nuclear counterstaining was performed with Mayer's hematoxylin for 2 min. Finally, the sections were dehydrated through increasing concentrations of ethanol and mounted. For negative controls, incubation step with the primary antibody was omitted to detect any background staining or false-positive results. The stained sections were observed under a light microscope by using the high magnification power ×200 and ×400 (Axioscope A1, Carl Zeiss, Jena, Germany).
Results
Histopathological changes
Hamster liver tissues were collected at different times following treatment with Ov plus NDMA. The histological results confirmed the results of previous studies (Loilome et al., 2006) . Briefly, the histopathological change was not detected in bile duct epithelial cells of the non-treated group. There were pathological changes have been observed as hyperplastic lesions at 30 days post-infection, precancerous lesions at 90 days post-infection and cancer at day 180 post-infection (p.i.) in Ov plus NDMA treated hamsters, respectively.
Altered expression of PI3K and increased activation of AKT along with PTEN suppression during CCA cholangiocarcinogenesis of Ov-infected hamster
The expression pattern of PI3K/AKT/PTEN signaling molecules including PI3K-p85α, PI3K-p110α, AKT1, p-AKT (T308), PTEN and p-PEN (S380, T382/383) during the carcinogenesis of Ov-induced hamster CCA was examined by IHC staining. The results are shown in Figure 1 .
The expressions of two PI3K subunits, p85α and p110α were observed in cytoplasm of bile duct epithelia. A faint positive stain was seen in normal bile ducts of the untreated group. The intensity and frequency of p85α positively stained bile duct epithelia increased in a time dependent manner in from hyperplastic bile ducts (14 days p.i), dysplastic bile ducts (90 days p.i) to cancer cells (180 days p.i.). Positive staining was observed also in inflammatory cells. A negative immunoreactivity for p110α was detected in the normal biliary cells of the untreated group. In Ov plus NDMA treated groups, an intense p110α staining was mainly detected in cancer cells developed at 180 days p.i. whereas low positive signals were observed at 14 days p.i., 30 days p.i. and 90 days p.i., respectively.
A very faint cytoplasmic signal of AKT1 staining was observed in the normal bile ducts of untreated group. In the Ov plus NDMA treated groups, the intensity of AKT1 positive stained cells increased in a time dependent manner during cholangiocarcinogenesis and the highest positive signal was seen when tumor has fully developed (180 days p.i.). Interestingly, nuclear staining of AKT1 was clearly observed in hyperplastic bile duct cells (30 days p.i), dysplastic bile duct cells (90 days p.i) as well as CCA cells and the highest positive signals were seen in cancer cells (180 days p.i.). An expression of p-AKT (T308) was not detected in the bile ducts of the untreated group. In Ov plus NDMA treated groups, the expression of p-AKT (T308) was detected in the cytoplasm of bile duct epithelia and the staining intensity is gradually increased during carcinogenesis process starting from 14 days to 180 days p.i especially the area where the liver fluke inhabit. In addition, the positive staining signals were seen also in hepatocytes and inflammatory cells.
The expression of PTEN was observed in normal bile duct cells. In the Ov plus NDMA treated group, decreased PTEN expression was detected along with the carcinogenesis processes especially in precancerous lesion (90 days p.i.) and CCA tissues (180 days p.i.) where absent or very weak expression was found. Moreover, the expression of PTEN in the stromal cells, including fibroblasts, lymphocytes, and endothelial cells was higher than normal bile ducts, hyperplasia, precancerous and CCA tissues. In addition, weak positive staining of phosphorylated PTEN (p-PTEN) was detected in the untreated control group as well as at 14 days p.i. and 30 days p.i. of the Ov plus NDMA treated group while progressively increased of p-PTEN in dysplastic bile ducts (90 days p.i.) and cancer cells (180 days p.i.). Interestingly, the expression of p-PTEN in CCA cells was observed in both the nucleus and cytoplasm, whereas no nuclear staining was detected in other treatment groups.
Wnt/β-catenin signaling pathway expression increased along with carcinogenesis processes
Furthermore, we investigated the expression and localization of Wnt proteins including Wnt3, Wnt3a, group, weak positive signal of p85α, AKT1, PTEN and p-PTEN were detected in biliary epithelia but negative staining of p110α and p-AKT (T308) was observed. In the treatment groups, expressions of p85α, p110α, AKT1, p-AKT (T308) and p-PTEN (S380, T382/383) in biliary epithelia increased conforming to CCA carcinogenesis. In contrast, weak or no staining of PTEN in biliary epithelia was detected in precancerous and cancerous tissues at 90 and 180 days post-treatment, respectively. Nuclear staining of p110α was detected at 90 and 180 days posttreatment. Nuclear staining of p-PTEN (S380, T382/383) was observed in the CCA group at 180 days post-treatment Wnt5a and Wnt7b as well as β-catenin, which are key effectors of canonical Wnt signaling during tumorigenesis of opisthorchiasis-associated CCA in a hamster model. The results are shown in Figure 2 .
In the control group, the expression of Wnt3 was not observed, whereas the Wnt3 expression increased and was related to the progression of carcinogenesis processes in the treatment groups. At 14 days p.i. and 30 days p.i., Wnt3 expression was detected only in the cytoplasm of biliary epithelial cells while positive staining in both cytoplasm and nucleus of Wnt3 was observed at 90 days p.i. at which precancerous bile ducts were developed. The highest positive signal of Wnt3 was found in cytoplasmic and nuclear of cancer cells (180 days p.i.). In addition, positive staining of Wnt3 was seen in cytoplasm of hepatocyte while the expression was observed in cytoplasm and nucleus of inflammatory cells.
Wnt3a expression was detected in both untreated and treated groups. In the untreated group, Wnt3a was expressed in the cytoplasm and cell membrane of biliary epithelial cells, although the signal was faint. The number of positive cells and staining intensity of Wnt3a in cytoplasm and cell membrane were increased in treated groups related to CCA development. In addition, increased nuclear accumulation of Wnt3a was found in precancerous lesions (90 days p.i.) as well as CCA cells (180 days p.i.). In addition, Wnt3a expression in hepatocytes and inflammatory cells was recognized.
Expression of Wnt5a was found in both the untreated and treated groups. The results show that Wnt5a is localized in the cytoplasm of the normal bile ducts, the hyperplastic bile duct and precancerous lesions. In tumor cells, Wnt5a is localized in both the cytoplasm and the nucleus. The intensity of Wnt5a positive signals increased over the time during the 14 days p.i. to 180 days p.i. at which CCA fully developed. The expression of Wnt5a in cytoplasm of hepatocytes and inflammatory cells was also observed.
No positive immunostaining of Wnt7b was detected in the tissues of the untreated group. In the Ov plus NDMA treated groups, expression of Wnt7b was observed in both the cytoplasm and nucleus of biliary cells and the expression increased in a time dependent manner during carcinogenesis. However, the most intense reaction of Wnt7b immunostaining was prominently seen the nucleus of the bile duct epithelial cells, whereas cytoplasmic staining signals were faint.
We next examined the expression of β-catenin, a key downstream player of the Wnt signaling cascade. As shown in Figure2, β-catenin immunoreactivity was observed in all animal groups. In the control group, expression of β-catenin exhibited faint cytoplasmic and cell membrane staining in normal biliary cells while there was an increase in the number of positively stained cells in both the cytoplasm and the cell membrane in treatment groups. Moreover, at 90 days p.i. and 180 days p.i. when precancerous lesions and CCA had developed, the remarkable nuclear localization of β-catenin was observed.
The expressions of all proteins in the present study are summarized in Table2.
Discussion
Several studies has indicated that CCA is caused by dysregulation of the tumor suppressor genes or oncogenes (Loilome et al., 2011; Namwat et al., 2012; Dokduang et al., 2014) However, the molecular mechanism(s) for CCA carcinogenesis remains unclear. Several studies have demonstrated that alteration of PI3K/AKT/PTEN and Wnt/ β-catenin was found in many cancers and these pathways may serve as the potential targets for cancer treatment (Gong et al., 2012; Pandurangan, 2013; Jannesari-Ladani et al., 2014; Tan et al., 2014) . This is the first report of the alteration of the protein components comprising the PI3K/ AKT/PTEN and Wnt/β-catenin pathway in a hamster model of Ov-induced CCA carcinogenesis. Previous studies, we have demonstrated an increase in PI3K/AKT activation, which correlated with PTEN suppression by loss of activation and phosphorylation in human CCA tissues (Yothaisong et al., 2013) . Moreover, another study has indicated that a secretory product, parasitic glutathione S-transferase (GST) produced from Ov can promote cell proliferation through increased activation of AKT (Daorueang et al., 2012) . Here we demonstrated an elevated expression as well as activation of the PI3K/AKT pathway during CCA carcinogenesis. Furthermore, strong DOI:http://dx.doi.org/10.7314/APJCP.2014.15.23.10463 Opisthorchis viverrini Infection Activates PI3K/AKT/PTEN and Wnt/β-catenin Signaling in a Cholangiocarcinogenesis Model staining of p-AKT (T308) was observed in the bile ducts in close proximity to Ov, suggesting that activation of AKT is related to infection and inflammation which might contribute to increased cell proliferation. In addition, increased expression of p110α in the CCA group was consistent with our previous findings that demonstrated overexpression of p110α with 90% in human CCA tissues (Yothaisong et al., 2013) . In addition, the present study has shown a decreased expression of a tumor suppressor PTEN in the precancerous and CCA groups which was consistent with increased PTEN phosphorylation at these time points. This indicated that the tumor activity of PTEN was suppressed by the loss of expression and phosphorylation as has been shown in previous studies (Yang et al., 2013; Yothaisong et al., 2013) . Additionally, these results are consistent with Xu et al., who found similar results in a mouse model (Xu et al., 2006) . Moreover, our results show that the positive staining signals of phosphorylated PTEN in CCA group were seen in the cytoplasm as well as in the nucleus of tumor cells. This may be due to the effect of phosphorylation of PTEN at Ser380/Threo382/ Threo383 which may promote nuclear accumulation (Patel et al., 2013) . Moreover the expression of phosphorylated PTEN has been detected in many cancers, such as lung cancer (David, 2001) , prostate cancer (Koumakpayi et al., 2010; Patel et al., 2013) , and glioblastoma (Fenton et al., 2012) . Therefore, our results suggest that PTEN inactivation by phosphorylation is responsible for PI3K/ AKT activation during CCA carcinogenesis.
Recently, we have demonstrated that expression of Wnt3a, Wnt5a, Wnt7b and β-catenin was significantly increased in human CCA tissues (Loilome et al., 2014) , which led us to hypothesize that activation of Wnt/β-catenin signaling could also be a driving force during CCA development. Therefore, we investigated the expression of Wnt proteins and a β-catenin in the present study. Our results showed that all the Wnt3, Wnt3a, Wnt5a, Wnt7b proteins examined, and a key downstream β-catenin were up-regulated in Ov-induced hamster CCA. The expression patterns of all Wnt/β-catenin components studied in Ovinduced hamster CCA were consistent with expression patterns in human CCA which we have previously reported (Loilome et al., 2014) . Our results show nuclear positive staining in CCA group for all Wnt proteins examined. Positive nuclear staining cells of Wnt3 and Wnt3a occurred in bile ducts in the precancerous lesions (90 days p.i.). Moreover, the nuclear positive staining cells of Wnt7b were found at all time points after treatment with the maximum intensity and maximum numbers of positive staining cells present when tumors had developed. These data suggest that nuclear localization of Wnt proteins may play important roles in cancer development. In addition, Wnt proteins expression are found in the nuclear part of the other cancer types, such as in melanoma (Bachmann et al., 2005; Da Forno et al., 2008) and gastric cancer .
Additionally, we revealed that the expression of β-catenin was seen in the membrane and the cytoplasm of positive cells which were observed in both the control and treatment groups. However, the intensity of β-catenin immunoreactivity was faint in the control group. Furthermore, accumulation of nuclear localization of β-catenin was found in the precancerous lesions (90 days p.i) and increased positive nuclear staining cells with high intensity was found when CCA had fully developed (180 days p.i). These results support previous studies that demonstrated the accumulation of nuclear β-catenin in CCA tissues (Sugimachi et al., 2001; Lim et al., 2008; Loilome et al., 2014) .
In conclusion, our results showed that activation of the PI3K/AKT signaling pathway along with PTEN suppression was potentially responsible for Ov-induced CCA development. Moreover, the increased expression of the Wnt protein family during CCA carcinogenesis was related to β-catenin nuclear translocation, which serves as a modulator of cell proliferation. This indicates that increased activation of PI3K/AKT/PTEN and Wnt/β-catenin signaling might be the underlying mechanisms which drive the development of CCA. Therefore, targeting components of these particular pathways may prove beneficial for the development of effective and treatment and prevention strategies for CCA.
